CMILF yields 2628.12% · JNJ yields 2.13%● Live data
📍 CMILF pulled ahead of the other in Year 1
Combined, CMILF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CMILF + JNJ for your $10,000?
Capella Minerals Limited, together with its subsidiaries, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It primarily explores for gold, copper, and lithium deposits, as well as for silver and zinc deposits. The company holds 100% interests in the Southern Gold Line project in Sweden; Hessjøgruva Project located in the northern Røros Mining District, Norway; Vaddas-Birtavarre Copper-Cobalt project in northern Norway; and Kjøli and Løkken Project in the Trøndelag County. It also holds interests in the Domain, Manitoba, and Savant Lake projects in Ontario, Canada; Aakenus-Katajavaara project in northern Finland; Perho project located in Southern Finland; and Sierra Blanca Gold-Silver Project in Santa Cruz, Argentina. The company was formerly known as New Dimension Resources Ltd. and changed its name to Capella Minerals Limited in November 2020. Capella Minerals Limited was incorporated in 2005 and is based in Mission, Canada.
Full CMILF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.